These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8382810)

  • 1. Interaction of deltorphin with opioid receptors: molecular determinants for affinity and selectivity.
    Lazarus LH; Salvadori S; Attila M; Grieco P; Bundy DM; Wilson WE; Tomatis R
    Peptides; 1993; 14(1):21-8. PubMed ID: 8382810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helix-inducing alpha-aminoisobutyric acid in opioid mimetic deltorphin C analogues.
    Bryant SD; Guerrini R; Salvadori S; Bianchi C; Tomatis R; Attila M; Lazarus LH
    J Med Chem; 1997 Aug; 40(16):2579-87. PubMed ID: 9258365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function of negative charge in the "address domain" of deltorphins.
    Lazarus LH; Salvadori S; Santagada V; Tomatis R; Wilson WE
    J Med Chem; 1991 Apr; 34(4):1350-5. PubMed ID: 1849997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermenkephalin and deltorphin I reveal similarities within ligand-binding domains of mu- and delta-opioid receptors and an additional address subsite on the delta-receptor.
    Charpentier S; Sagan S; Delfour A; Nicolas P
    Biochem Biophys Res Commun; 1991 Sep; 179(3):1161-8. PubMed ID: 1656944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereospecificity of amino acid side chains in deltorphin defines binding to opioid receptors.
    Lazarus LH; Salvadori S; Balboni G; Tomatis R; Wilson WE
    J Med Chem; 1992 Apr; 35(7):1222-7. PubMed ID: 1313878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid receptor selectivity reversal in deltorphin tetrapeptide analogues.
    Lazarus LH; Salvadori S; Tomatis R; Wilson WE
    Biochem Biophys Res Commun; 1991 Jul; 178(1):110-5. PubMed ID: 1648906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular determinants of receptor affinity and selectivity of the natural delta-opioid agonist, dermenkephalin.
    Sagan S; Amiche M; Delfour A; Mor A; Camus A; Nicolas P
    J Biol Chem; 1989 Oct; 264(29):17100-6. PubMed ID: 2551895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular dynamics conformations of deltorphin analogues advocate delta opioid binding site models.
    Bryant SD; Attila M; Salvadori S; Guerrini R; Lazarus LH
    Pept Res; 1994; 7(4):175-84. PubMed ID: 7696838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformationally restricted deltorphin analogues.
    Schiller PW; Weltrowska G; Nguyen TM; Wilkes BC; Chung NN; Lemieux C
    J Med Chem; 1992 Oct; 35(21):3956-61. PubMed ID: 1331451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of 1-aminocycloalkane-1-carboxylic acid-substituted deltorphin analogues: unique delta and mu opioid activity in modified peptides.
    Breveglieri A; Guerrini R; Salvadori S; Bianchi C; Bryant SD; Attila M; Lazarus LH
    J Med Chem; 1996 Feb; 39(3):773-80. PubMed ID: 8576920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [D-Ala2]deltorphin II analogs with high affinity and selectivity for delta-opioid receptor.
    Sasaki Y; Ambo A; Suzuki K
    Biochem Biophys Res Commun; 1991 Oct; 180(2):822-7. PubMed ID: 1659404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between receptor affinity and topography of N-terminally extended and bridged [Tyr1-->Asp4]deltorphin C analogues: novel probes for the delta-opioid receptor.
    Salvadori S; Bryant SD; Temussi PA; Bundy DM; Attila M; Tomatis R; Lazarus LH
    Eur J Pharmacol; 1993 Jan; 230(3):357-61. PubMed ID: 8382619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
    Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
    Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational restriction of the phenylalanine residue in a cyclic opioid peptide analogue: effects on receptor selectivity and stereospecificity.
    Schiller PW; Weltrowska G; Nguyen TM; Lemieux C; Chung NN; Marsden BJ; Wilkes BC
    J Med Chem; 1991 Oct; 34(10):3125-32. PubMed ID: 1656045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The aspartic acid in deltorphin I and dermenkephalin promotes targeting to delta-opioid receptor independently of receptor binding.
    Sagan S; Charpentier S; Delfour A; Amiche M; Nicolas P
    Biochem Biophys Res Commun; 1992 Sep; 187(3):1203-10. PubMed ID: 1329732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phe3-substituted analogues of deltorphin C. Spatial conformation and topography of the aromatic ring in peptide recognition by delta opioid receptors.
    Salvadori S; Bryant SD; Bianchi C; Balboni G; Scaranari V; Attila M; Lazarus LH
    J Med Chem; 1993 Nov; 36(24):3748-56. PubMed ID: 8254604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational properties of deltorphin: new features of the delta-opioid receptor.
    Temussi PA; Picone D; Tancredi T; Tomatis R; Salvadori S; Marastoni M; Balboni G
    FEBS Lett; 1989 Apr; 247(2):283-8. PubMed ID: 2541018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Para-substituted Phe3 deltorphin analogues: enhanced selectivity of halogenated derivatives for delta opioid receptor sites.
    Salvadori S; Bianchi C; Lazarus LH; Scaranari V; Attila M; Tomatis R
    J Med Chem; 1992 Dec; 35(25):4651-7. PubMed ID: 1335080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor.
    Amiche M; Sagan S; Mor A; Pelaprat D; Rostene W; Delfour A; Nicolas P
    Eur J Biochem; 1990 May; 189(3):625-35. PubMed ID: 2161761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermorphin interaction with rat brain opioid receptors: involvement of hydrophobic sites in the binding domain.
    Lazarus LH; Wilson WE; Guglietta A; de Castiglione R
    Mol Pharmacol; 1990 Jun; 37(6):886-92. PubMed ID: 2163014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.